Follicular hyperplasia on the face subsequent to therapy with sorafenib. A new skin side effect
Author:
Publisher
Wiley
Subject
Infectious Diseases,Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-3083.2008.03003.x/fullpdf
Reference4 articles.
1. BAY 43-9006 exhibits broad spectrum oral anti-tumor activity and targets the Raf/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis;Wilhelm;Cancer Res,2004
2. Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growh factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors;Clark;Clin Cancer Res,2005
3. Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor;Lacouture;Clin Exp Dermatol,2006
4. Sorafenib-induced erythema multiforme;MacGregor;J Am Acad Dermatol,2007
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sorafenib-Induced Spiny Follicular Hyperkeratosis: A Case Report with Review of Literature;Indian Journal of Medical and Paediatric Oncology;2023-05-12
2. Fármacos antiangiogénicos y piel: efectos cutáneos adversos de sorafenib, sunitinib y bevacizumab;Actas Dermo-Sifiliográficas;2014-12
3. Antiangiogenic Agents and the Skin: Cutaneous Adverse Effects of Sorafenib, Sunitinib, and Bevacizumab;Actas Dermo-Sifiliográficas (English Edition);2014-12
4. A review of cutaneous toxicities from targeted therapies in the treatment of colorectal cancers;J GASTROINTEST ONCOL;2013
5. Kutane Nebenwirkungen der medikamentösen Tumortherapie;Der Hautarzt;2011-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3